Program
Print program
passwell2016 Program
Print Full programTime | Session/Lecture info |
---|---|
09:00-09:45 | Sunday, May 1, 2016
|
09:00-09:30 |
Get-together and light refreshments
|
09:30-09:45 |
Michal Neeman, PhD, Vice-President, Weizmann Institute of Science
Liran Shlush, MD, PhD, Weizmann Institute of Science Levia Passwell |
09:45-13:00 | Session I
Chair: Tsvee Lapidot, PhD (Weizmann Institute of Science, Israel) |
09:45-10:30 |
Karl Skorecki, MD , Rambam Health Care Campus, Israel
An evolutionary arms race delivers a rare example of a common variant ?
common disease high risk association
|
10:30-11:00 |
Ravi Majeti, MD, PhD , Stem Cell Institute, Stanford School of Medicine, USA
Pre-leukemic hematopoietic stem cells in acute myeloid leukemia
|
11:00-11:30 |
Coffee Break
|
11:30-12:00 |
Liran Shlush, MD, PhD, Weizmann Institute of Science, Israel, and Visiting Physician, Rambam Health Care Center, Israel, and Princess Margaret Cancer Centre, Canada
Leukemia evolution
|
12:00-12:30 |
Ido Amit, PhD , Weizmann Institute of Science, Israel
Single cell genomic analysis of hematopoietic progenitors: Towards a refined model of hematopoiesis
|
12:30-13:00 |
John Welch, Washington University, USA
Order of mutations in AML: Implications for biology, residual disease detection,
and treatment
|
13:00-14:30 | Lunch
|
14:30-17:45 | Session II
Chair: Martin Ellis, MD (Meir Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Israel) |
14:30-15:15 |
Shai Izraeli, MD , Safra Children’s Hospital, Sheba Medical Center, Israel
Leukemia as a developmental disorder
|
15:15-15:45 |
Olivier Bernard, PhD , Institut Gustave Roussy, France
The origin of lymphoproliferative disorders
|
15:45-16:15 |
Coffee Break
|
16:15-16:45 |
Ruud Delwel, PhD , Erasmus Medical Center, The Netherlands
Oncogenic enhancers and acute myeloid leukemia
|
16:45-17:15 |
Jacob Rowe, MD , Rambam Health Care Campus and Shaare Zedek Medical Center, Israel
Advances in the treatment of adult ALL
|
17:15-17:45 |
Discussion
|